prof. Peter Bujdák, MD, PhD.

1.

Kováčik V, Maciak M, Baláž V, Babeľa J, Kubas V, Bujdák P, Beňo P. Advanced Reconstruction of Vesicourethral Support (ARVUS) during robot-assisted radical prostatectomy: first independent evaluation and review of other factors influencing 1 year continence outcomes. World Journal of Urology. 2020 

 Q1

 IF 4,226

2.

Kralik M, Cvecka J, Buzgo G, Putala M, Ukropcova B, Ukropec J, Killinger Z, Payer J, Kollarik B, Bujdak P, Raastad T, Sedliak M. Strength training as a supplemental therapy for androgen deficiency of the aging male (ADAM): study protocol for a three-arm clinical trial. BMJ Open. 2019 

 Q2

 IF 2,496

3.

Weibl P, Klatte T, Laurinc P, Tomaškin R, Shariat SF, Helbich M, Fackovcova D, Bujdák P. Patient's behavior and attitudes toward the management of benign prostatic hyperplasia among patients with the risk of disease progression: prospective study by "Prostate and Expectations of Treatment Epidemiology Research (PETER) study group". Wiener klinische Wochenschrift. 2015 

 Q3

 IF 0,836

4.

Weibl P, Laurinc P, Tomaškin R, Klatte T, Shariat F S, Helbich M, Fačkovcova D, Bujdák P. Patient's and physician's behavior on the management of benign prostatic hyperplasia among the patients at the risk of clinical progression. A multicenter noninterventional trial in Slovakia by "Prostate and Expectations of Treatment: Epidemiology Research" (PETER) study group. Wiener klinische Wochenschrift. 2015 

 Q3

 IF 0,836

5.

Ondrus D, Pribylincová V, Breza J, Bujdák P, Miklosi M, Reznícek J, Zvara V. The incidence of tumours in renal transplant recipients with long-term immunosuppressive therapy. International Urology and Nephrology. 1999

 ---

 ---